Clearside Biomedical IncQ) expected to post a loss of 10 cents a share - Earnings Preview
I'm PortAI, I can summarize articles.
Clearside Biomedical IncQ) is anticipated to report a loss of 10 cents per share for the quarter ending June 30, 2025, despite an expected revenue increase of 88.9% to $170,000. The average analyst rating is "hold," with a median 12-month price target of $5.00, significantly above its last closing price of $0.38. The earnings estimates have remained unchanged over the last three months, with a breakdown of recommendations showing 1 strong buy, 6 holds, and no sells.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments